Search

Christine Beeton

from Pearland, TX
Age ~51

Christine Beeton Phones & Addresses

  • 2603 Rusting Creek Dr, Pearland, TX 77584 (281) 993-4165
  • 2020 Business Center Dr, Pearland, TX 77584 (713) 436-1336
  • Irvine, CA
  • Seabrook, TX

Work

Company: Baylor college of medicine Jul 2015 to Jun 2019 Position: Co-director of the graduate program in molecular physiology and biophysics

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Aix - Marseille University 1997 to 2001 Specialities: Immunology

Skills

Cell Biology • Cell Culture • Biophysics • Laboratory • Immunology • Biochemistry • Physiology • Animal Models • Life Sciences • Cell • Western Blotting • Flow Cytometry • Science • Immunohistochemistry • Tissue Culture • Elisa • Lifesciences • Immunoassays • Translational Research • Ion Channels • Laboratory Skills

Languages

French • English

Interests

Autoimmunity • Allergy • Potassium Channels In the Immune System

Industries

Research

Resumes

Resumes

Christine Beeton Photo 1

Director Of The Graduate Program In Immunology And Microbiology

View page
Location:
2603 Rusting Creek Dr, Pearland, TX 77584
Industry:
Research
Work:
Baylor College of Medicine Jul 2015 - Jun 2019
Co-Director of the Graduate Program In Molecular Physiology and Biophysics

Baylor College of Medicine Jul 2015 - Jun 2019
Director of the Graduate Program In Immunology and Microbiology

Baylor College of Medicine Jul 2015 - Jun 2019
Associate Professor

Baylor College of Medicine Feb 2008 - Sep 2014
Assistant Professor

Baylor College of Medicine Feb 2008 - Sep 2014
Academic Director of the Cytometry and Cell Sorting Core
Education:
Aix - Marseille University 1997 - 2001
Doctorates, Doctor of Philosophy, Immunology
Aix - Marseille University 1996 - 1997
Aix - Marseille University 1993 - 1996
Master of Science, Masters, Bachelors, Bachelor of Science, Biochemistry, Immunology
Skills:
Cell Biology
Cell Culture
Biophysics
Laboratory
Immunology
Biochemistry
Physiology
Animal Models
Life Sciences
Cell
Western Blotting
Flow Cytometry
Science
Immunohistochemistry
Tissue Culture
Elisa
Lifesciences
Immunoassays
Translational Research
Ion Channels
Laboratory Skills
Interests:
Autoimmunity
Allergy
Potassium Channels In the Immune System
Languages:
French
English

Publications

Us Patents

Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels

View page
US Patent:
8440621, May 14, 2013
Filed:
Nov 1, 2011
Appl. No.:
13/286939
Inventors:
George K. Chandy - Laguna Beach CA, US
Christine Beeton - Irvine CA, US
Michael William Pennington - New Jersey CA, US
Assignee:
The Regents of the University of California - Oakland CA
Bachem Biosciences, Inc. - King of Prussia PA
International Classification:
A61K 38/00
A61K 38/16
A61P 3/04
A61P 25/00
US Classification:
514 174, 514 177
Abstract:
Analogs of ShK toxin and methods for using such ShK analogs. The ShK analogs generally comprise ShK toxin attached to a chemical entity (e. g. an atom, molecule, group, residue, compound, moiety, etc. ) that has an anionic charge. The ShK analogs may be administered to human or non-human animal subjects to cause inhibition of potassium channels or to otherwise treat diseases or disorders. In some embodiments, the chemical entity to which the ShK toxin is attached may be chosen to provide selective inhibition of certain potassium channels (e. g. , Kv1. 3 channels) over other potassium channels (e. g. , Kv1. 1 channels). In come embodiments, the chemical entity to which the ShK toxin is attached may include a fluorophore and such fluorophore-tagged ShK analogs may be used in flow cytometry alone, or in conjunction with class II tetramers that can detect autoreactive cells.

Analogs Of Shk Toxin And Their Uses In Selective Inhibittion Of Kv1. 3 Potassium Channels

View page
US Patent:
20080221024, Sep 11, 2008
Filed:
Oct 7, 2005
Appl. No.:
11/663398
Inventors:
George K. Chandy - Laguna Beach CA, US
Christine Beeton - Irvine CA, US
William Michael Pennington - Cherry Hill NJ, US
International Classification:
A61K 38/17
C07K 14/435
C12Q 1/02
A61P 37/00
US Classification:
514 12, 530324, 435 29
Abstract:
Analogs of ShK toxin and methods for using such ShK analogs. The ShK analogs generally comprise ShK toxin attached to a chemical entity (e.g. an atom, molecule, group, residue, compound, moiety, etc.) that has an anionic charge. In some embodiments the chemical entity attached to the ShK toxin may comprise an amino acid residue. The ShK analogs may be administered to human or non-human animal subjects to cause inhibition of potassium channels or to otherwise treat diseases or disorders. In some embodiments, the chemical entity to which the ShK toxin is attached may be chosen to provide selective inhibition of certain potassium channels (e.g., Kv1.3 channels) over other potassium channels (e.g., Kv1.1 channels). In come embodiments, the chemical entity to which the ShK toxin is attached may include a fluorophore, thereby providing a fluorophore tagged ShK analog. Such fluorophore tagged ShK analogs may be used in flow cytometry alone, or in conjunction with class II tetramers that can detect autoreactive cells.

Novel Scorpion Toxin Analogue And Method For Treating Autoimmune Diseases

View page
US Patent:
20160264634, Sep 15, 2016
Filed:
Oct 28, 2013
Appl. No.:
15/032454
Inventors:
- Clayton, Victoria, AU
- Louisville KY, US
- Houston TX, US
Michael PENNINGTON - Shelbyville KY, US
Christine BEETON - Pearland TX, US
International Classification:
C07K 14/435
Abstract:
A novel peptide analogue of the toxin HsTX1 is disclosed along with its application as, for example, a therapeutic agent for treating an autoimmune disease such as multiple sclerosis (MS) or rheumatoid arthritis (RA). The analogue comprises a peptide with an amino acid substitution at amino acid position 14 of the wild-type (WT) peptide sequence (or a position corresponding to position 14 of the WT peptide sequence). The analogue exhibits selectivity for Kv1.3 over Kv1.1 and other potassium channels relative to the WT peptide.

Antioxidants Having Aromatic Structures Reacting With Superoxide

View page
US Patent:
20160175292, Jun 23, 2016
Filed:
Dec 22, 2015
Appl. No.:
14/978448
Inventors:
James Tour - Bellaire TX, US
Redwan Huq - Houston TX, US
Jason A. Mann - Houston TX, US
Almaz Jalilov - Houston TX, US
Lizanne Nilewski - Houston TX, US
Tom Kent - Houston TX, US
Christine Beeton - Pearland TX, US
International Classification:
A61K 31/4375
Abstract:
Disclosed is a method of treating diseases which are: reactive oxygen species mediated, ischemic or reperfusion-related, or T-cell mediated, including autoimmune diseases. The method is administering a therapeutically effective amount of a formulation wherein the active ingredient includes non-phenolic aromatic structures that are electron deficient and are capable of converting the superoxide radical to O; and/or of converting superoxide radical to oxygen and hydrogen peroxide, or pharmaceutically acceptable salts of said structures. Also disclosed is a method of diagnosing and treating such diseases and conditions.

Wikipedia References

Christine Beeton Photo 2

Christine Beeton

Christine Beeton from Pearland, TX, age ~51 Get Report